Company Management

Du är här:

ChemoTech has a very competent management and Board of Directors with extensive expertise and substantial experience of medical research and clinical work, as well as of the international healthcare industry.

Arne Bojesson

CFO

Arne Bojesson is MSc in Business Administration from the Stockholm School of Economics. He has many years of experience from various management positions, among others in listed medical device companies such as Althin Medical and Phase Holographic Imaging. He has also worked in investment banking. He started his career in the Electrolux Group.

Ashim Purohit

Chairman of Scandinavian Meditech India Pvt Ltd

Born 1968. Chairman of Scandinavian Meditech India Pvt Ltd 2017.

Education and experience: Engineering Graduate with Diploma in Management & Marketing. 29 years’ experience including customer service, sales, product mgt, marketing & general mgt. Formative 14 years with Siemens Medical India, in India.

Current assignments: Own growth consulting, leadership mentoring & entrepreneurship guidance practice – for GTM approach in India.  Director of Advisory Board at AGD Biomedicals Pvt Ltd. Anchor Mentor & Advisor at Sensivision Health Technologies.

Previous assignments (last five years): Founding President & CEO of Getinge’s Medical Systems (MAQUET) in India.

Göran Hellers

Member of the Board of Directors

Born 1944. Member of the Board of Directors since 2013.

Not independent in relation to the Company and, being the Company´s second largest shareholder, not independent in relation to major shareholders.

Education and experience: Licensed physician. Formerly head of the surgical department at Huddinge Hospital.

Current assignments: Chairman of Scandinavian Real Heart AB, Hellers Medical AB, Laprotech AB. Board member of Directors of Scandinavian Care AB, Scandinavian Care Investment AB, Scandinavian Care Consulting AB, Scandinavian Care Holding AB, Fricks Property & Equity AB, Scandinavian Medical Development Mind AB, MDM Medical Development Mind AB.

Previous assignments (last five years): Chairman, Transsafe AB.

Göran Hellers holds 165,000 A-shares and 163,000 B-shares, via company.

IngaLill Forslund Larsson

Chairman of the Board of Directors

Born 1954. Member of the Board of Directors since 2018.

Independent of the Company and independent of major shareholders.

Education and experience: University degree in Economics and Marketing. Leg. Midwife and Nurse. Extensive experience from marketing & sales and business development. Business responsibility as Head of Urology Global Marketing at Ferring Pharmaceuticals and commercial roles for AstraZeneca.

Current assignments: Board member of LIDDS Pharmaceuticals, Truly Labs AB. CEO, co-owner and board member of private real estate companies (Ellet Assets AB; Fastighets AB Olshög, Nible Invest AB, Nöbbe Gård AB, Nöbbe Gård Projekt AB)

Previous assignments (last five years): Chairman of the Board XImmune AB, board member LU Bioscience AB.

Johan Wennerholm

Member of the Board of Directors

Born 1968. Member of the Board of Directors since 2019

Independent of the Company and independent of major shareholders.

Education and experience: B.Sc in Business and Administration (University of Lund). Has extensive experience from public listed companies

Current assignments: Board Member in Invent Medic Sweden AB (publ), Board Member in GelExcell Competence AB, Board Member in Urethra Medical & Care AB, Board Member and owner in Nordic Infrastructure AB

Previous assignments: CFO in Invisio AB (publ), CFO in CellaVision AB (publ), CEO in Occlutech International AB, CFO in Enzymatica AB (publ) samt CEO in VS Gruppen Syd AB

Maria Persson

Product and R&D Director

Born 1979. Product and R&D Director since 2017.

Currently on maternity leave.

Education and experience: BS Biomedical chemistry. Has a wide experience of life science through her previous experience at companies as Baxter, Gambro and Semcon. Maria has worked with product development, clinical trials, regulatory questions and has experience of electroporation from previous work within biotech.

Current assignments: –

Previous assignments (last five years): Project Manager Baxter/Gambro.

Mohan Frick

CEO and Founder

Born 1974. Member of the Board of Directors and CEO since 2015.

Not independent in relation to the Company and, being the Company´s largest shareholder, not independent in relation to major shareholders.

Education and experience: BA, Marketing, Management, Lund University. 20 years’ experience as market manager, sales manager and Board member of life science companies. Has among other things held positions in Arjo AB, Getinge, Navigator Communications, Insulution AB, OnMeD and SYSMEX.

Current assignments: Chairman of Scandinavian MediTech (Indian subsidiary), Fricks Property & Equity Invest AB.

Previous assignments (last five years): Member of the Board of Directors of Insulution AB 2009-2011, Onmed International 2012-March 2013, Onmed India Private Limited 2011-June 2014. Member of the Advisory Board for Billion Minds Foundation 2009-2014.

Mohan Frick holds 285,000 A-shares and 240,599 B-shares, direct  or via company.